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Abstract
Hypermutation and class switch recombination of immunoglobulin genes are antigen-activated
mechanisms triggered by AID, a cytidine deaminase. AID deaminates cytidine residues in the DNA
of the variable and the switch regions of the immunoglobulin locus. The resulting uracil induces
error-prone DNA synthesis in the case of hypermutation or DNA breaks that activate non-
homologous recombination in the case of class-switch recombination. In vitro studies have
demonstrated that AID deaminates single-stranded but not double-stranded substrates unless AID is
in a complex with RPA and the substrate is actively undergoing transcription. However, it is not clear
whether AID deaminates its substrates primarily as a monomer or as a higher order oligomer. To
examine the oligomerization state of AID alone and in the presence of single stranded DNA substrates
of various structures, including loops embedded in double-stranded DNA, we used atomic force
microscopy (AFM) to visualize AID protein alone or in complex with DNA. Surprisingly, AFM
results indicate that most AID molecules exist as a monomer and that it binds single-stranded DNA
substrates as a monomer at concentrations where efficient deamination of single-stranded DNA
substrates occur. The rate of deamination, under conditions of excess and limiting protein, also imply
that AID can deaminate single-stranded substrates as a monomer. These results imply that non-
phosphorylated AID is catalytically active as a monomer on single stranded DNA in vitro, including
single-stranded DNA found in loops similar to those transiently formed in the immunoglobulin switch
regions during transcription.
1. Introduction
B cells undergo three mechanisms of somatic gene alteration that profoundly impact the
recognition and binding of foreign antigen by antibodies. V(D)J recombination is a
developmentally programmed mechanism that generates the diverse pre-immune antibody
repertoire. Class switch recombination (CSR) and somatic immunoglobulin (Ig) hypermutation
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(SHM) are antigen-activated mechanisms that lead to the formation of isotype-switched, high
affinity antibodies characteristic of the secondary immune response [1–7]. Both CSR and SHM
as well as Ig gene conversion in other species such as rabbit and chicken require the cytidine
deaminase, AID [8–12]. AID deaminates cytidines, generating uracils in the DNA encoding
the variable and the switch regions of the immunoglobulin locus [13,14]. In CSR, the uracil is
removed from the DNA of the involved switch regions by uracil DNA glycosylase (UNG),
generating abasic sites [14]. The requirement for at least part of the non-homologous end-
joining double-strand break DNA repair machinery in CSR suggests that these abasic sites lead
to breaks that trigger the switch reaction [15–17]. Indeed, AID-dependent DNA breaks have
been extensively documented for the switch regions [17–22]. In SHM, the resolution of the
AID-generated uracil in the DNA is less clear. It appears that hypermutation at G:C base pairs
that results from deamination of cytidine residues in the DNA of Ig V regions can originate
from replication over the uracil leading to G:C transitions. Alternatively, it can originate from
excision of uracil by UNG presumably via a base excision repair mechanism leading to both
transitions and transversions at G:C base pairs [14]. Mutations at A:T base pairs, while entirely
dependent on AID (AID deficient mice lack mutations from both A:T and G:C base pairs), are
likely an indirect result of AID-mediated deamination involving the mismatch DNA repair
proteins and translesion synthesis DNA polymerases (TLS) [23–36; for a review see 37]. The
requirement for mismatch repair proteins and TLS DNA polymerases for the A:T phase of
hypermutation suggests that the G:U mismatch generated by AID initiates a mismatch repair
synthesis patch that utilizes the error-prone TLS polymerases instead of the high fidelity DNA
polymerases [37]. This model is still speculative since the resolution of the AID-generated
uracil in the DNA of Ig V regions leading to mutations at A:T base pairs remains unclear.
Finally, it is possible that in addition to the DNA encoding Ig V regions, AID may also
deaminate an RNA encoding molecules critical to SHM and CSR [38], although an RNA target
has not been identified.
AID deaminates single-stranded but not double-stranded DNA in vitro [39–42] except for
double-stranded DNA that is actively undergoing transcription [42–45], particularly if AID is
phosphorylated by PKA and in a complex with RPA. AID preferentially deaminates
microsequences associated with SHM hotspots (WRCY) [39,46–49], providing a rationale for
the existence of SHM hotspots that are predominantly found in the complementarity
determining regions (CDR’s). Data from “pull-down” assays using tagged-AID proteins [50]
and from structural modeling based on homologous cytidine deaminases [51] suggest that AID
may function as a dimer to deaminate DNA. However, it remains unclear whether or not AID
is catalytically active as a monomer. Herein, we examine AID deamination of single-stranded
DNA alone or embedded within double-stranded DNA in the form of loops. We determined
the oligomeric state of the protein by direct visualization using atomic force microscopy (AFM)
[52]. Surprisingly, the AFM experiments demonstrate that the dominant AID species is a
monomer and that dimerization is not promoted by the presence of single-stranded DNA. These
AFM data taken together with a kinetic analysis of deamination suggest that a monomer of
AID is sufficient to catalyze the deamination of single-stranded DNA in vitro.
2. Methods and Materials
2.1 Preparation of oligonucleotide substrates
The oligonucleotides used in the deamination assays and the predicted structures of the double-
stranded oligonucleotides are depicted in figure 1. The “L-oligo” was designed based on the
primer used by Yu and colleagues [46] while the single-stranded DNA oligonucleotide (AID1
primer) was based on the CDR2 sequence of the human Ig heavy chain VH3-30-3.
Oligonucleotides (100 μM) were 5′-end labeled with γ-32P ATP (3000 Ci/mmol, Amersham
Biosciences) using Optikinase (United States Biochemical Corp.) according to the
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manufacturer’s instructions. The reaction was terminated by the addition of 20 mM EDTA,
and the enzyme was heat denatured by incubation for 10 minutes at 65 °C. After labeling, the
free nucleotides were removed by gel filtration chromatography (Micro Bio-spin-6, Bio-Rad).
For the generation of double-stranded substrates, the labeled oligonucleotide was annealed
with the complimentary strand [(AID1+AID2 = double strand), (AID1+AID8 = Bubble), and
(AID1+AID9 = Loop) see Fig. 1] using 1.2 molar excess of cold oligonucleotides in the
presence of 100 mM KCl, heated at 65°C for 5 minutes and slowly cooled to room temperature.
The duplexes were analyzed on a native 10% polyacrylamide gel.
2.2 Deamination assays
Typically, a reaction mixture (10 μl) containing 2–100 nM radioisotope-labeled
oligonucleotide substrate, 5nM-2000nM purified human AID protein (Enzymax, University
of Kentucky), 100ng of RNase A (Qiagen) and 1 unit of uracil DNA glycosylase (Invitrogen)
was incubated for 15 min at 37 °C in a buffer containing: 25 mM Tris-Cl, pH 8.0, 50 mM NaCl,
and 5 mM EDTA (see scheme in Fig. 2a). C’terminus (histidine)6-tagged AID protein was
purified from E. coli by Enzymax (The University of Kentucky, Advanced Science and
Technology Commercialization Center) by affinity column (HiTrap Chelating HP ™ followed
by HiTrap Heparin HP ™, GE Healthcare) using an elution buffer consisting of 50 mM Tris
(pH of 7.5), 5 mM β-mercaptoethanol, 10% glycerol and 500 Mm NaCl. Also, a mutant form
of human AID wherein the second cysteine in the active site (position 90) was mutated to
alanine was used as a control and it was purified under identical conditions as the wild type
AID, by Enzymax. We confirmed the purity of the AID protein preparation using a Coomassie
stained gel with SimplyBlue SafeStain (Invitrogen, Carlsbad, USA) per manufacturer’s
instructions, and in deamination assays, the wild type protein but not the mutant form,
deaminated a single-stranded DNA substrate (Supplemental figure). To examine deamination
at limiting and excess AID protein concentrations, deamination reactions were carried out at
final AID protein concentrations ranging from 5 nM to 2 μM and oligo concentrations ranging
from 2 nM to 100 nM. For a subset of samples, RNAse A (400 ng) (Qiagen) was pre-incubated
with AID for 30 minutes prior to addition of the oligo. The reaction was stopped by adding 1
μl of 2 M NaOH and heated for 5 min at 95°C. Ten μl of formamide was added and samples
were heated at 95°C for 5 min and loaded on 10% denaturing polyacrylamide gels containing
7 M urea. Gels were run in 1X Tris borate-EDTA (TBE) buffer under constant voltage at
ambient temperature. Gels were dried and visualized by autoradiography using the phosphor-
imager Typhoon 9400 (Amersham Biosciences) and the bands quantified by ImageQuant
software (Molecular Dynamics). Deamination rates were determined by fitting the percentage
of deamination with time to first order exponentials. All deamination reactions were repeated
at least two times.
2.2 Atomic Force Microscopy
AID protein was diluted to final concentrations of 5, 10, and 20 nM in imaging buffer (20 mM
HEPES, pH 7.3/10 mM MgOAc/100mM NaOAc). In a subset of experiments AID was
incubated at 500 nM and then quickly diluted to 10 nM for deposition. Deposition of AID at
concentrations higher than 20 nM resulted in too many proteins on the surface, thereby
preventing a statistical analysis. For depositions in the presence of DNA, AID was incubated
with various concentrations of DNA oligonucleotides (5 nM-50 nM) for 30 minutes at room
temperature prior to deposition. After incubation, 10 μl of AID in the presence or absence of
DNA was deposited onto freshly cleaved mica (Spruce Pine Mica Company, Spruce Pine, NC).
The sample was rinsed immediately with nanopure water, excess water was wicked from the
surface using filter paper, and the surface was then dried using a stream of nitrogen. AFM
images were captured in air using either a Nanoscope III or IIIa (Digital Instruments, Santa
Barbara, CA) microscope in tapping mode. Pointprobe Plus tapping mode silicon probes
(Molecular Imaging, Tempe, AZ) with resonance frequencies of approximately 170 kHz were
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used for imaging. Images were collected at a speed of 2–3 Hz with an image size of 1 μm × 1
μm at 512 × 512 pixel resolution. Each experiment was repeated at least twice. Volume analysis
was done as previously described [52]. The program Kaleidagraph (Synergy Software, Reading
PA) was used to generate statistical plots.
3. Results
3.1 AID deaminates DNA loops and bubbles embedded in double-stranded DNA
To examine the deamination activity of AID on various single-stranded DNA substrates
including substrates containing loops or bubbles, and to determine substrates for AFM analysis,
we designed oligonucleotides containing the structures depicted in Fig. 1. Deamination
reactions were done for the various substrates following the scheme depicted in Fig. 2a. AID
deaminated all substrates tested, including the loop and bubble substrates, but not double-
stranded DNA (Figs. 2b and c). The best substrate for AID is the L-oligo, modeled after the
oligonucleotide designed by Yu and colleagues [46], with over 50% deamination after 15
minutes, followed by the single-stranded oligonucleotide modeled after V regions of human
IgV heavy chains (over 40% deaminated product at 15 minutes) (Fig. 2c). Even at high protein
concentrations, in the single-stranded oligonucleotide that contains multiple dC’s throughout
its length, the majority of product is deaminated at or near the site resembling AID-mediated
immunoglobulin somatic hypermutation hotspots (AGCA) (Figs. 1 and 2b), as seen previously
by us and other groups [39,46–49]. Although the substrate containing a single-stranded 8-
nucleotide loop is not deaminated as rapidly as the single-stranded oligonucleotides, its
deamination is significantly faster than that of the substrate containing a 10-nucleotide bubble.
For example, after a 15 minute incubation with AID, greater than 20 % of the loop substrate
was deaminated while only 11% of the bubble substrate was deaminated (Fig. 2c). Deamination
of single-stranded hairpin loops was consistently better than that of double-stranded loops,
regardless of the size of the loops, at all concentrations of protein and DNA tested (data not
shown). This lower rate of deamination of bubble substrates probably results from formation
of non-canonical base pairs in the loop, thereby disrupting the accessibility of the cytidine to
AID [53]. Taken together, these results indicate that AID preferentially deaminates cytosines
that are maximally exposed. This preference for single-stranded vs. double-stranded loops
might reflect AID-deamination of exposed single-stranded DNA in hairpin loops that might
be formed due to the palindromic sequences often associated with CSR regions [54] or single-
stranded DNA regions formed during transcription.
3.2 AFM reveals AID exists predominantly as a monomer, even in the presence of substrate
AFM, which yields topographic images of molecules deposited on a surface, has proven to be
a powerful tool for determining the oligomerization state of proteins as well as protein-protein
association constants [52,55–62]. Specifically, we have demonstrated that the volume
measured by AFM exhibits a linear dependence on the molecular weight of proteins with V =
1.2(MW) − 14.7, where V is the volume as measured by AFM and MW is the molecular weight
of the protein [52,61]. Using this relationship, the oligomerization states for many different
proteins and protein-protein complexes have been determined in the presence and absence of
DNA [52,55–58,61–62]. Accordingly, we have used this method to determine the
oligomerization state of AID in the presence and absence of DNA substrates (either the L-oligo
or the single-stranded loop DNA substrate).
Figure 3a shows representative AFM images of AID in the absence of DNA. To determine the
oligomerization state of AID, the volume of each of the peaks (AID proteins) in the AFM
images was determined from a large number of images (3028 peak volumes). Figure 3c shows
the distribution of volumes in the absence and presence of DNA. In the absence of DNA, the
distribution shows a single peak at ~15 nm3. This volume is consistent with the predicted
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volume of 15 nm3 for a monomer of His-tagged AID (AID monomer MW = 24.8kDa). Notably,
only a few percent of the peaks have volumes corresponding to the predicted volume of a dimer
of AID (45 nm3). Increasing the protein concentration from 5 nM to 20 nM or incubating at
500nM and immediately diluting to 10 nM before deposition (see methods) did not increase
the population of species with larger volumes (data not shown). These results indicate that AID
exists predominantly as a monomer at these concentrations and suggests that if a dimer forms
it has a relatively weak association constant [52].
To determine if DNA induces dimerization, AID was incubated with 10nM to 50nM of the L-
oligo or the loop substrate for 30 minutes before deposition. The concentrations of AID protein
and oligonucleotide used in these AFM experiments are within the range of concentrations
where significant deamination of substrate by AID after 30 minutes of incubation is observed
(for example see deamination at 20 nM AID with 10 nM oligo, Fig. 3b). We used 5, 10, and
20 nM of AID protein as well as an incubation concentration of 500nM, immediately followed
by deposition at 10nM (see above). In addition, because addition of RNase A is necessary for
deamination, it is possible that bound RNA, known to inhibit the deamination reaction [39],
might interfere with dimerization and/or DNA binding. To test this possibility, we pre-
incubated AID with RNase A for 30 minutes before adding DNA (L-oligo), and imaged as
usual. To assure that AID was active under these conditions, we tested the deamination activity
of AID when it was preincubated with RNase A for 30 minutes versus adding AID at the start
of the deamination assay. As seen previously, RNase A was required for deamination to occur,
however, pre-incubation with RNase A did not change the rate of deamination (Fig. 4). The
concentration of AID was 20-fold higher than that of RNase A so that RNase A would only be
a minor population (5 %) of the protein in the AFM images. We analyzed between 800 and
4000 protein data points for each AID and oligo concentrations. Figure 3c shows the
distribution of volumes (810 peak volumes) for AID that was treated with RNaseA and
incubated with the L-oligo. This distribution is indistinguishable from that of AID that was not
treated with RNaseA and incubated with the L-oligo or with the loop substrate, or from any of
the protein/oligo concentration combinations (data not shown). The major peak in the
distribution is found at ~18 nm3. This peak, while still corresponding to monomeric AID, is
shifted to a slightly higher volume compared to AID in the absence of oligonucleotide (Figure
3c). This increase in volume in the presence of oligonucleotide is consistently seen for both
AID treated and untreated with RNaseA, and it likely represents oligonucleotide being bound
to monomeric AID. These results suggest that binding of AID to DNA does not induce
dimerization of AID, because there is no significant increase in the fraction of peaks with
volumes corresponding to the dimer (~45 nm3) in the presence of DNA substrate.
3.3 AID can deaminate single-stranded DNA as a monomer
To determine if AID can function as a monomer, we measured the rates of deamination of the
L-oligo substrate (100 nM) as a function of AID concentration (5 nM to 500nM) (Fig. 5). For
5 nM and 20 nM AID, where our AFM data indicate that AID is primarily monomeric, with
100 nM oligonucleotide, the initial rates (determined by linear fits to the data for timepoints ≤
20 minutes) are 0.15 min−1 and 0.73 min−1, respectively (Fig. 5a). This increase in rate (4.8-
fold) is within error of the expected increase for the 4-fold increase in enzyme concentration
[63]. Furthermore, increasing the AID concentration to 100 nM increases the rate to 1.27
min−1, but increasing it further to 500 nM results in only a small increase in deamination rate
(1.34 min−1) (Fig. 5a). These latter results indicate that the DNA is nearly saturated at 100 nM
AID, which is a one-to-one ratio of AID monomer to DNA. If the observed activity were due
solely to AID dimers, we would expect to see at least a 2-fold increase in rate going from 100
nM to 500 nM AID. These results strongly suggest that AID can function as a monomer to
deaminate cytosine in single-stranded DNA.
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To further verify that this observed activity is due to the monomer and not to an increase in the
population of dimers, we examined the rates of deamination of 10 nM L-oligo with 2-fold (20
nM, where less than 20% of the population has volumes that could be attributed to the dimer
in the presence of oligo) and 50-fold (500 nM) excess AID. If a small fraction of AID dimers
were responsible for the observed activity, we would expect to see an increase in deamination
rate with increasing AID concentration from 20 nM to 500 nM, because at 20 nM AID, the
dimer concentration (20% of the population corresponds to ~ 3 nM AID dimer) would be below
the DNA concentration. Consequently, if the dimer were responsible for the observed activity,
we should see an increase in deamination activity upon increasing the AID concentration from
20 to 500 nM, as we observed for the experiments with the DNA in excess (Fig. 5a). Inspection
of Figure 5b reveals that the rate of deamination is the same for both of these concentrations.
These results indicate that at 10 nM L-oligo, a two-fold excess of AID is sufficient to bind all
of the L-oligo and catalyze deamination. This result is consistent with the measured binding
affinities of AID for oligonucleotide substrates, which are in the sub to low nanomolar range
[64]. These kinetic data together with the AFM data strongly support the conclusion that AID
is functional as a monomer on single-stranded DNA in vitro.
4. Discussion
We found that AID is catalytically active as a monomer on single-stranded DNA in vitro, even
when the single-stranded DNA region is embedded in double-stranded DNA in the form of
loops. We did not observe a significant population of volumes consistent with AID dimers by
AFM for any of the protein/oligo concentrations, including concentrations where well over
50% of the oligo is deaminated (Figure 3c, data not shown). Pre-incubation of AID at
concentrations up to 500nM also failed to alter the percentage of volumes corresponding to the
dimer. In addition, the dependence of the deamination rates on AID concentration is consistent
with AID functioning as a monomer for both the experiments in which the AID concentration
is lower than the DNA concentration (Fig. 5a) and for those in which the AID monomer
concentration is higher than the DNA concentration (Fig. 5b). While these results demonstrate
that AID is active as a monomer on single-stranded DNA in vitro, they do not preclude the
possibility that AID may also function as a dimer in vivo (or in vitro), where it may be post-
translationally modified via phosphorylation [45] (see below).
Comparison of the rates of deamination on single-stranded DNA loops within double-stranded
DNA with deamination rates on substrates devoid of any secondary structure such as the L-
oligo indicates that even short loops of single-stranded DNA can be deaminated by AID
relatively well, albeit with less efficiency than DNA sequences in which the cytidine is expected
to be completely exposed, such as the L-oligo (Figs. 1 and 2). These results imply that even at
low concentrations, as found in the nucleus of cells expressing AID, monomeric AID could
catalyze the deamination of cytidine to uracil as long as it can find a suitable substrate in the
form of exposed single-stranded DNA patches or loops. In support of this idea, recent data
suggests that AID can bind and deaminate single-stranded DNA in a variety of configurations
such as displaced single-stranded DNA loops or patches [64–67] and even in negatively
supercoiled double-stranded DNA [68] formed during transcription. These results might
explain why AID can access and deaminate DNA in non-natural substrates such as in DNA of
E. coli cells, non-lymphoid cells, and non-Ig genes that are actively transcribed [14,69–71],
and wherein B-cell specific post-translational modifications of AID do not occur. If for
example, dimerization is optimally promoted when AID is specifically phosphorylated in
activated B cells, these results imply that non-phosphorylated monomeric AID in other cells
could potentiate inappropriate deamination of dC in non-immunoglubulin gene targets. It will
be interesting to determine whether monomeric AID contributes to non-targeted AID-mediated
deamination in B cell lymphomas or when expressed in non-B cells. If so, the oligomeric status
of AID may contribute yet another layer of regulation similar to transcriptional regulation and
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intracellular localization that keep cells expressing AID from experiencing its mutagenic
activity in non-intended targets [72–74]. In addition it is likely that, in B cells, targeting co-
factors sharpen AID’s substrate specificity uniquely to the Ig V and CSR regions [75], although
these putative co-factors have yet to be identified.
Our results do not imply that the dimer does not form or is not functional. In the AFM images,
a few percent of the molecules have volumes that correspond to the dimer and other higher
order oligomeric states, although increasing the concentration from 5 nM to 20 nM or following
incubation at 500nM, does not result in any detectable changes in the population of molecules
with higher volumes. However, It is clear from our studies that in vitro, i) the monomer is the
predominant species in the absence of substrate (at the concentrations examined), ii) the
monomer is catalytically active on single-stranded DNA, and iii) binding to single-stranded
DNA substrate does not induce any significant dimerization. A recent study that examined the
binding of GST-tagged and His-tagged AID supports our conclusion that AID can function as
a monomer [64]. Specifically, in band-shift assays of AID with a DNA substrate containing a
single-stranded bubble, the GST-tagged-AID, which is forced to be a dimer by GST
dimerization [76], causes dramatically greater shifts of the DNA than does the His-tagged-
AID, consistent with His-tagged-AID binding to DNA as a monomer.
A recent report by Wang and colleagues, suggests that AID dimerization is required for optimal
class switch recombination in vivo; however, these studies examined co-immunoprecipitation
of AID with two different tags from cell extracts, and therefore, the apparent dimerization in
these studies could be dimerization mediated by other proteins and not a direct interaction of
two AID molecules [77]. In addition, whether or not this “dimerization” is also required for
immunoglobulin hypermutation where deamination of dC’s throughout the length of the V
region is evident was not tested. Several other reasons may account for the differences between
our results and those reported in the previous study [77]. Namely, we have found that in its
most proximal activity, as a deaminase, monomeric AID can deaminate dC’s in vitro, whereas
class switch recombination in vivo, may require a higher order oligomeric state of AID to help
align specific dC’s in switch regions or for other functionalities. Also, it is possible that AID
acts both as a monomer and as a dimer in vivo, perhaps differentially for hypermutation and
class switch recombination; a hypermutation phenotype was not reported in that study for the
dimer mutants. While both of these processes require AID, they also likely require different
co-factors, occur independently of each other, and target different regions of the heavy chain
Ig locus. Finally, it is conceivable that phosphorylation or other post-translational
modifications of AID in activated B cells may promote dimerization, while the non-modified
form of AID acts as a monomer, with less efficiency. In fact, ectopically-expressed AID is not
phosphorylated and yet it can deaminate dC in non-lymphoid cells, but at a lower frequency
(14, 44, 69–71).
The observation that AID exhibits catalytic activity as a monomer in vitro is in contrast to other
deaminases studied to date, including the RNA editing enzymes such as Apobec-1, and the
adenosine deaminases [78–81]. Interestingly, these deaminases require dimerization not only
for their enzymatic activity but also for specificity of the substrate. For example, homodimers
comprising a wild type monomer and a mutant monomer of ADAR1 or ADRAR2 lose only
half the ability to deaminate a non-specific dsRNA substrate, in a sequence-independent
manner but lose nearly 70% site-selective activity on natural substrates, such as the RNA
encoding serotonin 2C subtype receptor [81]. Consequently, it is possible that while monomeric
AID is catalytically active, a homodimer may confer some kind of substrate specificity wherein
interaction between the monomers helps align a specific cytosine residue for deamination. This
idea is interesting because deamination of cytosine in an RNA target would require exquisite
targeting not only to a particular RNA species, but a particular cytosine in its sequence. Such
a level of specificity may require dimerization as seen with RNA editing enzymes such as
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Apobec-1 [78]. However, an RNA target for AID has not been identified although indirect
evidence supports the possibility [reviewed in 38]. Alternatively, an AID homodimer, while
not required for deamination, may help the simultaneous deamination of cytosine on both DNA
strands, as previously suggested [49], an idea supported by our findings predicting that each
monomer of AID in a putative dimer can catalyze deamination of single-stranded DNA
independently. Additional support for this notion comes from theoretical analysis based on a
comparison of yeast RNA-editing deaminase to AID suggesting that for the homodimer, both
monomers are able to catalyze deamination of two cytosines within the same nucleic acid strand
or in opposite strands [51]. In addition, a recent structure of the AID homolog APOBEC2
shows that while APOBEC2 forms a tetramer, which is a dimer of dimers, the putative active
site is not near either the dimer or tetramer interface and each of the monomers appears to have
a fully intact active site [82]. Finally, it is important to note that although it is likely that AID
can form a dimer, there is no direct evidence for dimerization in vitro or in vivo [other than the
small population of dimers observed in this study (Fig. 3)], only inference from homology
models and co-immunoprecipitation of cell extracts [51,77]. It will be interesting to determine
whether AID catalyzes deamination as a monomer and/or dimer in vivo, and whether the
oligomeric state of AID contributes a previously unappreciated layer of functional plasticity
by modifying substrate specificity differentially for SHM or CSR, or for DNA vs RNA
substrates depending on whether a specific cytosine needs to be deaminated (as seen in RNA
deamination) versus several cytosines in a DNA substrate with some preference (i.e. hotspots)
but without requiring deamination of a specific residue.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Sequence of substrates used for deamination assays and predicted structures for the duplexed
oligonucleotides.
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AID deaminates single-stranded DNA in various configurations. A) Schematic representation
of deamination reaction and expected product following incubation of end-labeled
oligonucleotide with AID and UNG. B) AID deaminates most oligonucleotides where single-
stranded DNA (ssDNA) is exposed but fails to deaminate double-stranded DNA (dsDNA), C)
Quantitation of autoradiographs after deamination reactions. The substrate devoid of secondary
structure (L-oligo) deaminated best but there was substantial deamination of loop structures
over time. All reactions contained 2 nM oligonucleotide and 500 nM AID protein and were
repeated at least three times.
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Atomic Force Microscopy analysis of the oligomeric state of AID. A) 2 and 3-dimensional
view of AID protein alone deposited at a final concentration of 10 nM. B) Representative gel
image of the rate of deamination by AID when present at 20 nM concentration acting on 10
nM of L-oligo. The range of deaminated product at 30 minutes from 4 experiments for this
ratio of AID protein to oligonucleotide was 32%-49%. C) Volume distributions of AID in the
absence of DNA (black bars) and of RNaseA-treated AID in the presence of the L-oligo DNA
substrate (grey bars). These results are representative of 5, 10, and 20 nM AID alone (black
bars) and of 5, 10, and 20 nM AID in the presence of 10–50 nM of either the L-oligo and the
loop substrate oligonucleotide (grey bars). Similar results were obtained when the protein was
pre-incubated at 500nM with or without substrate, immediately diluted, and deposited at 10nM
concentrations. In all cases, the major peaks in the distributions are consistent with the expected
volume of an AID monomer (The predicted volumes (see text) of the monomer: (15 nm3) and
dimer (45 nm3) are shown on the x-axis.
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RNAse A is required for deamination, but pre-incubation does not alter the rate of deamination.
10 nM of L-oligo was incubated with 500 nM of AID protein without any RNaseA (triangles)
or with 400 ng RNaseA added either with the oligo (diamonds) or 30 minutes before the additon
of oligo (squares).
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Concentration dependence of deamination rates indicates that most of the catalysis on single-
stranded DNA oligonucleotide is from the monomer. A) Rate of deamination of 100 nM L-
oligo in the presence of 5 nM (diamonds), 20 nM (triangles), 100 nM (circles), and 500 nM
(squares) AID. The straight lines are linear fits to data points for times ≤ 20 minutes. The initial
rates, which were determined from the linear fits, are 0.15, 0.73, 1.27, and 1.34 min−1 for 5
nM, 20 nM, 100 nM, and 500 nM AID, respectively. B) Rate of deamination of 10 nM L-oligo
in the presence of 20 nM (squares) and 500 nM (circles) AID. The curves are first order
exponential fits to the data. The error bars represent the standard error from 3 or more
experiments.
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